HbA1c target: The higher doses of GIP/GLP-1 RA provided the most significant HbA1c reductions, with up to 30 percent of people who received the 10 mg and 15 mg doses achieving HbA1c levels of less than 5.7 percent, which is in the normal range for people without diabetes [18 percent (10 mg) and 30 percent (15 mg)]
Weight loss drugs might not work the same way on every body and individual results may vary
References 1 AllanK
Its not fully understood how these receptor agonists cause weight loss, but we know that GLP-1 reduces hunger and slows digestion, so they may make you feel fuller longer
"Multifunctionality and Possible Medical Application of the BPC 157 Peptide: Literature and Patent Review." Pharmaceuticals , 18(2):185, 2025
If you click on links or make a purchase through this page, we may earn a commission.* Ozempic , or semaglutide, is a glucagon-like peptide-1 (GLP-1) agonist drug that affects insulin and, as a result, blood sugar levels